Literature DB >> 2337942

Biliary excretion of metabolites of baicalin and baicalein in rats.

K Abe1, O Inoue, E Yumioka.   

Abstract

Biliary excretion of metabolites of baicalin, present in Scutellariae Radix, was investigated using rats. The bile of rats administered baicalin orally was shown to contain five major metabolites, which were identified as baicalein 6-O-beta-glucopyranuronoside (M1), 6-O-methyl-baicalein 7-O-beta-glucopyranuronoside (oroxylin A 7-O-beta-glucuronide (M2], baicalein 7-O-beta-glucopyranuronoside (M3), 6-O-beta-glucopyranuronosyl- baicalein 7-O-sulfate (M4), and baicalein 6,7-di-O-beta-glucopyranuronoside (M5) on the basis of chemical and spectroscopic evidence. The bile of rats treated with baicalein also contained the above metabolites. Slower biliary excretion of the metabolites after baicalin administration suggested that it was absorbed as baicalein after hydrolysis in the gastrointestinal tract. The total cumulative amounts of the five metabolites excreted in the bile during 30 h after oral administration of baicalin and that of baicalein were approximately 54% and 40% of the doses, respectively. In addition the bilary metabolites of both drugs were shown to be mainly composed of M5 and M4, which have high polarity and large molecular weight.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337942

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  10 in total

1.  Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice.

Authors:  Hien-trung Trinh; Eun-ha Joh; Ho-young Kwak; Nam-in Baek; Dong-hyun Kim
Journal:  Acta Pharmacol Sin       Date:  2010-05-10       Impact factor: 6.150

2.  The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study.

Authors:  T H Tsai; S C Liu; P L Tsai; L K Ho; A Y C Shum; C F Chen
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 3.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

4.  Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production.

Authors:  Naohiro Oshima; Tomofumi Shimizu; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2018-04-18       Impact factor: 2.343

5.  Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2.

Authors:  Teruaki Akao; Yoko Sakashita; Masato Hanada; Hirozo Goto; Yutaka Shimada; Katsutoshi Terasawa
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

6.  Pharmacokinetics, Prostate Distribution and Metabolic Characteristics of Four Representative Flavones after Oral Administration of the Aerial Part of Glycyrrhiza uralensis in Rats.

Authors:  Haifan Liu; Guanhua Chang; Wenquan Wang; Zuen Ji; Jie Cui; Yifeng Peng
Journal:  Molecules       Date:  2022-05-19       Impact factor: 4.927

7.  The role of intestinal microflora in anti-inflammatory effect of baicalin in mice.

Authors:  Myung-Ah Jung; Se-Eun Jang; Sung-Woon Hong; Myung Joo Hana; Dong-Hyun Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

8.  Compound to Extract to Formulation: a knowledge-transmitting approach for metabolites identification of Gegen-Qinlian Decoction, a traditional Chinese medicine formula.

Authors:  Xue Qiao; Qi Wang; Shuang Wang; Wen-Juan Miao; Yan-Jiao Li; Cheng Xiang; De-An Guo; Min Ye
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

9.  Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial.

Authors:  Li Ni; Zheng Wen; Xiaowen Hu; Wei Tang; Haisheng Wang; Ling Zhou; Lujin Wu; Hong Wang; Chang Xu; Xizhen Xu; Zhichao Xiao; Zongzhe Li; Chene Li; Yujian Liu; Jialin Duan; Chen Chen; Dan Li; Runhua Zhang; Jinliang Li; Yongxiang Yi; Wei Huang; Yanyan Chen; Jianping Zhao; Jianping Zuo; Jianping Weng; Hualiang Jiang; Dao Wen Wang
Journal:  Front Med       Date:  2021-04-28       Impact factor: 9.927

Review 10.  Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review.

Authors:  Risha Ganguly; Ashutosh Gupta; Abhay K Pandey
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.